Plain-English translation of NCT07546929 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 clinical trial testing , a new medication designed to help your body respond better to insulin and control blood sugar after meals. Researchers want to find the right dose and confirm that the medication is safe and effective for people with type 2 diabetes. About 300 people will participate in this study.
Many people with type 2 diabetes struggle to control their blood sugar even with current treatments like metformin. This medication is being tested because it targets a specific part of the body's glucose control system that may be impaired in type 2 diabetes, offering a potentially new way to help patients manage their condition.
You likely qualify if…
You likely don't qualify if…
You would take the medication or placebo twice daily by mouth while continuing your current diabetes management plan. The study will involve several visits to monitor your safety and see how well the medication works, including blood tests and heart rhythm checks. You'll be assigned to one of several dose levels or a placebo group so researchers can determine which dose works best.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States